Search

everythinglearnresearchcommunity

for

Search:↓

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The new minoxidil emulgel with marine-based polymers shows effective controlled drug release for hair growth treatment.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Combination therapies may be more effective for treating Folliculitis Decalvans than antibiotics alone.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Plant-derived exosomes show promise for healing skin wounds but need more research and trials.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.

Compound 7p shows strong potential as an anticancer agent.

Designing effective fluorescence microscopy experiments requires careful consideration of hardware, biological models, and imaging agents.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Mammoth hair grew faster than human hair and showed seasonal changes in growth and mineral content.

The ethosomal delivery system improves topical drug delivery and promotes hair growth.

Fetal wounds heal without scarring because of different biological factors, which could help improve adult wound healing.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Extracellular vesicles can help treat skin issues like wounds, hair loss, aging, and inflammation.